AU2003215706A1 - Orodispersible pharmaceutical composition comprising ivabradine - Google Patents
Orodispersible pharmaceutical composition comprising ivabradineInfo
- Publication number
- AU2003215706A1 AU2003215706A1 AU2003215706A AU2003215706A AU2003215706A1 AU 2003215706 A1 AU2003215706 A1 AU 2003215706A1 AU 2003215706 A AU2003215706 A AU 2003215706A AU 2003215706 A AU2003215706 A AU 2003215706A AU 2003215706 A1 AU2003215706 A1 AU 2003215706A1
- Authority
- AU
- Australia
- Prior art keywords
- ivabradine
- pharmaceutical composition
- orodispersible pharmaceutical
- orodispersible
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- ACRHBAYQBXXRTO-OAQYLSRUSA-N Ivabradine Chemical compound C1CC2=CC(OC)=C(OC)C=C2CC(=O)N1CCCN(C)C[C@H]1CC2=C1C=C(OC)C(OC)=C2 ACRHBAYQBXXRTO-OAQYLSRUSA-N 0.000 title 1
- 229960003825 ivabradine Drugs 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0200791 | 2002-01-23 | ||
| FR0200791A FR2834896B1 (en) | 2002-01-23 | 2002-01-23 | ORODISPERSIBLE PHARMACEUTICAL COMPOSITION OF IVABRADINE |
| PCT/FR2003/000198 WO2003061662A1 (en) | 2002-01-23 | 2003-01-22 | Orodispersible pharmaceutical composition comprising ivabradine |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| AU2003215706B8 AU2003215706B8 (en) | 2003-09-02 |
| AU2003215706A1 true AU2003215706A1 (en) | 2003-09-18 |
| AU2003215706B2 AU2003215706B2 (en) | 2007-08-02 |
Family
ID=27589555
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2003215706A Ceased AU2003215706B2 (en) | 2002-01-23 | 2003-01-22 | Orodispersible pharmaceutical composition comprising ivabradine |
Country Status (28)
| Country | Link |
|---|---|
| US (2) | US20050106238A1 (en) |
| EP (1) | EP1474152B1 (en) |
| JP (1) | JP4500052B2 (en) |
| KR (1) | KR100613550B1 (en) |
| CN (1) | CN1278688C (en) |
| AR (1) | AR038206A1 (en) |
| AT (1) | ATE348619T1 (en) |
| AU (1) | AU2003215706B2 (en) |
| BR (1) | BRPI0307056B1 (en) |
| CA (1) | CA2473203C (en) |
| CY (1) | CY1108854T1 (en) |
| DE (1) | DE60310526T2 (en) |
| DK (1) | DK1474152T3 (en) |
| EA (1) | EA007681B1 (en) |
| ES (1) | ES2278165T3 (en) |
| FR (1) | FR2834896B1 (en) |
| GE (1) | GEP20063820B (en) |
| HK (1) | HK1076741A1 (en) |
| MA (1) | MA27102A1 (en) |
| MX (1) | MXPA04007199A (en) |
| NO (1) | NO333698B1 (en) |
| NZ (1) | NZ533842A (en) |
| PL (1) | PL204938B1 (en) |
| PT (1) | PT1474152E (en) |
| SI (1) | SI1474152T1 (en) |
| UA (1) | UA78278C2 (en) |
| WO (1) | WO2003061662A1 (en) |
| ZA (1) | ZA200405129B (en) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2868777B1 (en) * | 2004-04-13 | 2006-05-26 | Servier Lab | NOVEL PROCESS FOR THE SYNTHESIS OF IVABRADINE AND ITS SALTS OF ADDITION TO A PHARMACEUTICALLY ACCEPTABLE ACID |
| FR2882553B1 (en) * | 2005-02-28 | 2007-05-04 | Servier Lab | CRYSTALLINE BETA FORM OF IVABRADINE HYDROCHLORIDE, PROCESS FOR PREPARING THE SAME, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME |
| EP1917979A4 (en) * | 2005-08-23 | 2009-06-03 | Astellas Pharma Inc | Therapeutic agent for atrial fibrillation |
| FR2894825B1 (en) * | 2005-12-21 | 2010-12-03 | Servier Lab | NOVEL ASSOCIATION OF SINUSAL IF CURRENT INHIBITOR AND CONVERSION ENZYME INHIBITOR AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME |
| FR2911279B1 (en) * | 2007-01-11 | 2009-03-06 | Servier Lab | USE OF IVABRADINE FOR THE PRODUCTION OF MEDICAMENTS FOR THE TREATMENT OF ENDOTHELIAL DYSFUNCTION |
| WO2010128525A2 (en) | 2009-05-04 | 2010-11-11 | Dinesh Shantilal Patel | A formulation of ivabradine for treating the cardiovascular disease |
| EP2579860B1 (en) | 2010-06-14 | 2014-04-23 | Ratiopharm GmbH | Ivabradine-containing pharmaceutical composition with modified release |
| CN103393611B (en) * | 2013-08-06 | 2015-08-19 | 南京正大天晴制药有限公司 | A kind of Ivabradine hydrochloride tablet and preparation method thereof |
| WO2016102423A1 (en) * | 2014-12-22 | 2016-06-30 | Ratiopharm Gmbh | Composition comprising ivabradine in a dissolved form |
| GR1008821B (en) | 2015-06-11 | 2016-08-01 | Φαρματεν Ανωνυμος Βιομηχανικη Και Εμπορικη Εταιρεια Φαρμακευτικων Ιατρικων Και Καλλυντικων Προϊοντων | Pharmaceutical composition comprising ivabradine hydrochloride and method for preparation thereof |
| CN106265582A (en) * | 2016-08-31 | 2017-01-04 | 辰欣药业股份有限公司 | A kind of hydrochloric acid Ivabradine sheet and preparation technology thereof |
| EP3993773A1 (en) * | 2019-07-01 | 2022-05-11 | Orion Corporation | Methods for administering (r)-n-[4-(1,4,5,6-tetrahydro-6-oxo-3-pyridazinyl)phenyl]acetamide |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AT376147B (en) * | 1980-12-15 | 1984-10-10 | Gergely Gerhard | METHOD AND DEVICE FOR GRANULATING A POWDER MIXTURE |
| DE3505433A1 (en) * | 1985-02-16 | 1986-08-21 | Basf Ag, 6700 Ludwigshafen | DIRECT TABLETING AIDS |
| DE3506276C1 (en) * | 1985-02-22 | 1986-04-24 | Meggle Milchindustrie Gmbh & Co Kg, 8094 Reitmehring | Direct tableting |
| JP3253127B2 (en) * | 1991-06-07 | 2002-02-04 | 帝國製薬株式会社 | Preparation containing bioactive polypeptide |
| FR2681862B1 (en) * | 1991-09-27 | 1993-11-12 | Adir Cie | NOVELS (BENZOCYCLOALKYL) ALKYLAMINES, THEIR PREPARATION PROCESS, AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. |
| FR2710265B1 (en) * | 1993-09-22 | 1995-10-20 | Adir | Bioadhesive pharmaceutical composition for the controlled release of active ingredients. |
| CA2179382C (en) * | 1994-01-31 | 2009-11-10 | Takao Mizumoto | Intrabuccally dissolving compressed moldings and production process thereof |
| US6024981A (en) * | 1997-04-16 | 2000-02-15 | Cima Labs Inc. | Rapidly dissolving robust dosage form |
| JP2001526662A (en) * | 1997-05-09 | 2001-12-18 | フェロンパテント リミテッド | Stabilization of interferon in aqueous solution for the production of sublingual tablets |
| AU741992B2 (en) * | 1998-03-06 | 2001-12-13 | Adare Pharmaceuticals S.R.L. | Fast disintegrating tablets |
| JP2983973B1 (en) * | 1998-10-13 | 1999-11-29 | 大正薬品工業株式会社 | Oral fast disintegrating solid preparation |
| JP2000273039A (en) * | 1999-01-20 | 2000-10-03 | Taisho Pharmaceut Co Ltd | Composition disintegrable in oral cavity |
| JP2001058944A (en) * | 1999-06-18 | 2001-03-06 | Takeda Chem Ind Ltd | Rapidly disintegrating solid formulation |
| ATE371439T1 (en) * | 2000-07-27 | 2007-09-15 | Roquette Freres | GRANULES CONSISTING OF STARCH AND LACTOSE |
| UA80393C2 (en) * | 2000-12-07 | 2007-09-25 | Алтана Фарма Аг | Pharmaceutical preparation comprising an pde inhibitor dispersed on a matrix |
| FR2818552B1 (en) * | 2000-12-26 | 2003-02-07 | Servier Lab | SOLID THERMOFORMABLE PHARMACEUTICAL COMPOSITIONS FOR THE CONTROLLED RELEASE OF IVABRADINE |
| FR2834889B1 (en) * | 2002-01-18 | 2004-04-02 | Roquette Freres | SOLID ORODISPERSIBLE PHARMACEUTICAL FORM |
-
2002
- 2002-01-23 FR FR0200791A patent/FR2834896B1/en not_active Expired - Fee Related
-
2003
- 2003-01-22 BR BRPI0307056-5A patent/BRPI0307056B1/en not_active IP Right Cessation
- 2003-01-22 CA CA2473203A patent/CA2473203C/en not_active Expired - Fee Related
- 2003-01-22 US US10/502,594 patent/US20050106238A1/en not_active Abandoned
- 2003-01-22 WO PCT/FR2003/000198 patent/WO2003061662A1/en active IP Right Grant
- 2003-01-22 NZ NZ533842A patent/NZ533842A/en not_active IP Right Cessation
- 2003-01-22 PL PL370161A patent/PL204938B1/en unknown
- 2003-01-22 DE DE60310526T patent/DE60310526T2/en not_active Expired - Lifetime
- 2003-01-22 SI SI200330632T patent/SI1474152T1/en unknown
- 2003-01-22 KR KR1020047011350A patent/KR100613550B1/en not_active IP Right Cessation
- 2003-01-22 AR ARP030100177A patent/AR038206A1/en unknown
- 2003-01-22 EP EP03731734A patent/EP1474152B1/en not_active Expired - Lifetime
- 2003-01-22 GE GE5627A patent/GEP20063820B/en unknown
- 2003-01-22 CN CNB038027119A patent/CN1278688C/en not_active Expired - Fee Related
- 2003-01-22 PT PT03731734T patent/PT1474152E/en unknown
- 2003-01-22 UA UA20040806963A patent/UA78278C2/en unknown
- 2003-01-22 AT AT03731734T patent/ATE348619T1/en active
- 2003-01-22 DK DK03731734T patent/DK1474152T3/en active
- 2003-01-22 AU AU2003215706A patent/AU2003215706B2/en not_active Ceased
- 2003-01-22 EA EA200400927A patent/EA007681B1/en not_active IP Right Cessation
- 2003-01-22 ES ES03731734T patent/ES2278165T3/en not_active Expired - Lifetime
- 2003-01-22 JP JP2003561606A patent/JP4500052B2/en not_active Expired - Fee Related
- 2003-01-22 MX MXPA04007199A patent/MXPA04007199A/en active IP Right Grant
-
2004
- 2004-06-28 ZA ZA2004/05129A patent/ZA200405129B/en unknown
- 2004-07-12 MA MA27776A patent/MA27102A1/en unknown
- 2004-08-18 NO NO20043440A patent/NO333698B1/en not_active IP Right Cessation
-
2005
- 2005-10-10 HK HK05108934A patent/HK1076741A1/en not_active IP Right Cessation
-
2007
- 2007-01-16 CY CY20071100061T patent/CY1108854T1/en unknown
-
2010
- 2010-06-23 US US12/803,280 patent/US20100267693A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2003220786A1 (en) | Orodispersible pharmaceutical composition comprising agomelatine | |
| AU2003291103A1 (en) | Pharmaceutical composition | |
| HK1076741A1 (en) | Orodispersible pharmaceutical composition comprising ivabradine | |
| HK1076742A1 (en) | Orodispersible pharmaceutical composition comprising agomelatine | |
| HK1076743A1 (en) | Orodispersible pharmaceutical composition comprising perindopril | |
| EP1425019A4 (en) | Pharmaceutical composition | |
| AU2003250372A1 (en) | Pharmaceutical composition | |
| AU2002302147A1 (en) | Pharmaceutical composition | |
| AUPR602501A0 (en) | Sustained release pharmaceutical composition | |
| AU2003260803A1 (en) | Sustained release pharmaceutical composition | |
| AU2002364468A1 (en) | Solid orally-dispersible pharmaceutical formulation | |
| AU2003215706A1 (en) | Orodispersible pharmaceutical composition comprising ivabradine | |
| AU2003215708A1 (en) | Orodispersible pharmaceutical composition comprising perindopril | |
| AU2003284460A1 (en) | Medicinal composition | |
| AU2003280799A1 (en) | Medicinal composition | |
| AU2003216503A1 (en) | Stable pharmaceutical compositions | |
| AUPR529701A0 (en) | Pharmaceutical composition | |
| AU2003280678A1 (en) | Medicinal composition | |
| AUPS188302A0 (en) | Pharmaceutical composition | |
| AU2003219238A1 (en) | Orodispersible pharmaceutical composition comprising testosterone | |
| AU2003219239A1 (en) | Orodispersible pharmaceutical composition comprising mitiglinide | |
| SI1467750T1 (en) | Orodispersible pharmaceutical composition comprising perindopril | |
| AU2002335161A1 (en) | Medicinal composition | |
| AU2003238900A1 (en) | Pharmaceutical formulation | |
| AUPS167102A0 (en) | Pharmaceutical composition |